Contrarian investors looking for a sectoral bet after the sharp rise in broader markets can consider pharmaceuticals stocks, which have been underperforming in recent times, according to fund managers and analysts. While several pharma companies continue to face pressure on profitability, their share valuations are cheaper, they said. Investors confused about which stocks to pick could consider mutual fund schemes that invest in pharma stocks.